Telo Genomics Corp.
TELO.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 988.50K | 960.10K | 879.80K | 739.80K | 922.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.92M | 1.93M | 1.89M | 1.75M | 1.91M |
| Operating Income | -1.92M | -1.93M | -1.89M | -1.75M | -1.91M |
| Income Before Tax | -1.93M | -1.94M | -1.87M | -1.73M | -1.91M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.93 | -1.94 | -1.87 | -1.73 | -1.91 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.93M | -1.94M | -1.87M | -1.73M | -1.91M |
| EBIT | -1.92M | -1.93M | -1.89M | -1.75M | -1.91M |
| EBITDA | -1.91M | -1.92M | -1.87M | -1.73M | -1.89M |
| EPS Basic | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 377.15M | 351.33M | 322.96M | 294.25M | 288.79M |
| Average Diluted Shares Outstanding | 377.15M | 351.33M | 322.96M | 294.25M | 288.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |